Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-14.2%
operating margin TTM
-9.81%
revenue TTM
672.64 Million
revenue per share TTM
14.54$
valuation ratios | |
|---|---|
| pe ratio | -12.41 |
| peg ratio | 1.29 |
| price to book ratio | 1.59 |
| price to sales ratio | 1.77 |
| enterprise value multiple | 41.58 |
| price fair value | 1.59 |
profitability ratios | |
|---|---|
| gross profit margin | 71.6% |
| operating profit margin | -9.81% |
| pretax profit margin | -9.0% |
| net profit margin | -14.2% |
| return on assets | -6.41% |
| return on equity | -12.07% |
| return on capital employed | -5.53% |
liquidity ratio | |
|---|---|
| current ratio | 2.40 |
| quick ratio | 2.00 |
| cash ratio | 0.89 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 229.71 |
| operating cycle | 288.70 |
| days of payables outstanding | 35.08 |
| cash conversion cycle | 253.62 |
| receivables turnover | 6.19 |
| payables turnover | 10.40 |
| inventory turnover | 1.59 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.41 |
| debt equity ratio | 0.82 |
| long term debt to capitalization | 0.33 |
| total debt to capitalization | 0.45 |
| interest coverage | -5.11 |
| cash flow to debt ratio | 0.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.87 |
| cash per share | 10.49 |
| operating cash flow per share | 4.10 |
| free cash flow operating cash flow ratio | 0.94 |
| cash flow coverage ratios | 0.30 |
| short term coverage ratios | 0.94 |
| capital expenditure coverage ratio | 17.81 |
Frequently Asked Questions
When was the last time Pacira BioSciences, Inc. (NASDAQ:PCRX) reported earnings?
Pacira BioSciences, Inc. (PCRX) published its most recent earnings results on 06-11-2024.
What is Pacira BioSciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pacira BioSciences, Inc. (NASDAQ:PCRX)'s trailing twelve months ROE is -12.07%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pacira BioSciences, Inc. (PCRX) currently has a ROA of -6.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PCRX's net profit margin stand at?
PCRX reported a profit margin of -14.2% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PCRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.40 in the most recent quarter. The quick ratio stood at 2.00, with a Debt/Eq ratio of 0.82.